Regional Vice President of Sales The Retirement Plan Company
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
Compass
|
AimPoint Pension
|
Loan & Distribution Specialist AimPoint Pension
|
Bates & Company, Inc.
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
GAO Report: Post-ACA Trends in Usual and Customary Prices for Commonly Used Prescription Drugs
U.S. Government Accountability Office [GAO] Mar. 14, 2011
28 pages. "Prescription drug spending in 2009 totaled approximately $250 billion, of which $78 billion -- or about 31 percent -- was spent by the federal government. Prescription drug spending by the federal government, patients, and third-party payers, including employers, is driven by many factors, including the prices paid for drugs.... Some media reports have suggested that prescription drug prices may have increased more during the debate leading up to passage of the [[ACA]] in March 2010 compared to other recent years. We were requested to examine recent trends in drug prices for brand-name and generic pharmaceuticals. [GAO-11-306R, published Feb. 10, 2011, released Mar. 14, 2011]
|
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |